KYTX vs TYL · $488.8M cap vs P/E 89, rev $1.26B
Kyverna Therapeutics, Inc. Common Stock (KYTX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
KYTX does not have a complete income-statement cache yet.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
KYTX currently screens at market cap $488.8M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the KYTX and TYL stock pages for the full models.
Not investment advice.